| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1035201112 |
| P356 | DOI | 10.1186/GB-2006-7-7-R54 |
| P932 | PMC publication ID | 1779567 |
| P698 | PubMed publication ID | 16836768 |
| P5875 | ResearchGate publication ID | 6948388 |
| P50 | author | Jan Buer | Q117207046 |
| Astrid Westendorf | Q21402720 | ||
| P2093 | author name string | Robert Geffers | |
| Carlos A Guzman | |||
| Wiebke Hansen | |||
| Andres J Schrader | |||
| Anke Franzke | |||
| Andreas Jeron | |||
| Michael Probst-Kepper | |||
| Tanja Toepfer | |||
| Susanne Pfoertner | |||
| P2860 | cites work | Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells | Q79317453 |
| A comparison between SNaPshot, pyrosequencing, and biplex invader SNP genotyping methods: accuracy, cost, and throughput | Q80291335 | ||
| Activation of CD8+ regulatory T cells by human placental trophoblasts | Q81827336 | ||
| Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells | Q24301436 | ||
| Significance analysis of microarrays applied to the ionizing radiation response | Q24606608 | ||
| Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 | ||
| The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games | Q24683018 | ||
| PTTG/securin activates expression of p53 and modulates its function | Q24792982 | ||
| Molecular profile of synovial fibroblasts in rheumatoid arthritis depends on the stage of proliferation. | Q24800971 | ||
| Sources of variability and effect of experimental approach on expression profiling data interpretation | Q24802502 | ||
| Characterization of adjacent breast tumors using oligonucleotide microarrays | Q24805954 | ||
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 | ||
| Cutting edge: Transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase | Q28217175 | ||
| The role of CD40-CD154 interaction in cell immunoregulation | Q28262622 | ||
| Transcription factor GATA-3 is required for development of the T-cell lineage | Q28587190 | ||
| The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development | Q28590049 | ||
| Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 | Q28591451 | ||
| NF-kappaB: linking inflammation and immunity to cancer development and progression | Q29614597 | ||
| An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 | ||
| Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self | Q29619194 | ||
| Genesis: cluster analysis of microarray data | Q29619630 | ||
| Regulatory T cells overexpress a subset of Th2 gene transcripts | Q31035510 | ||
| Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation | Q32058522 | ||
| Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms | Q33195020 | ||
| Analysis of gene expression in single live neurons | Q33209493 | ||
| Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. | Q33217202 | ||
| Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor | Q33935212 | ||
| Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 | ||
| CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 | ||
| A polymorphism in the TCF7 gene, C883A, is associated with type 1 diabetes | Q34199720 | ||
| High expression of TIAF-1 in chronic kidney and liver allograft rejection and in activated T-helper cells | Q34209456 | ||
| TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity. | Q34212836 | ||
| TIAF1 and p53 functionally interact in mediating apoptosis and silencing of TIAF1 abolishes nuclear translocation of serine 15-phosphorylated p53. | Q34298987 | ||
| Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models | Q34376868 | ||
| Interleukin-7: master regulator of peripheral T-cell homeostasis? | Q34382929 | ||
| Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance | Q34448410 | ||
| CD4+ CD25+ suppressor T cells: more questions than answers | Q34716304 | ||
| Natural versus adaptive regulatory T cells | Q35092554 | ||
| Apoptosis - the p53 network | Q35218060 | ||
| Antigen-induced regulatory T cells | Q35693709 | ||
| CD4+ CD25+ Treg: divide and rule? | Q35694441 | ||
| Human CD4+CD25+ regulatory T cells | Q35703495 | ||
| Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells | Q35810906 | ||
| Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis | Q35834701 | ||
| On the role of galectin-3 in cancer apoptosis | Q36103556 | ||
| Galectins as immunoregulators during infectious processes: from microbial invasion to the resolution of the disease | Q36135442 | ||
| Paths to understanding the genetic basis of autoimmune disease | Q36148396 | ||
| Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis | Q36167827 | ||
| In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. | Q36370315 | ||
| Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells | Q36399149 | ||
| Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo | Q36400127 | ||
| Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia | Q36403785 | ||
| FOXP3: of mice and men. | Q36427333 | ||
| Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes. | Q37721023 | ||
| Definition of regulatory network elements for T cell development by perturbation analysis with PU.1 and GATA-3. | Q38289001 | ||
| Fingerprints of anergic T cells | Q38300517 | ||
| Identification of genes involved in the initiation of human Th1 or Th2 cell commitment | Q38320010 | ||
| Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study. | Q38354018 | ||
| Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays | Q39600873 | ||
| Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays | Q39607930 | ||
| p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis | Q40579357 | ||
| Neuropilin-1: a surface marker of regulatory T cells | Q40584286 | ||
| Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen | Q40701079 | ||
| Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction | Q40848658 | ||
| Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells | Q40933105 | ||
| The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. | Q41998069 | ||
| Galectin 3 and its binding protein in rheumatoid arthritis. | Q42451393 | ||
| Control of immune responses by naturally arising CD4+ regulatory T cells that express toll-like receptors | Q42944823 | ||
| Upregulation of CD40--CD40 ligand system in patients with diabetes mellitus | Q44701088 | ||
| Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression | Q45106594 | ||
| Dimeric galectin-1 induces IL-10 production in T-lymphocytes: an important tool in the regulation of the immune response | Q45147481 | ||
| Identification of c-myc as a down-stream target for pituitary tumor-transforming gene | Q46290466 | ||
| The T cell activation marker CD150 can be used to identify alloantigen-activated CD4(+)25+ regulatory T cells | Q47626644 | ||
| Human CD4+CD25+ regulatory T cells share equally complex and comparable repertoires with CD4+CD25- counterparts | Q47644330 | ||
| Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. | Q47682161 | ||
| Cutting edge: ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis | Q47810532 | ||
| Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death | Q48020712 | ||
| Current issues for DNA microarrays: platform comparison, double linear amplification, and universal RNA reference. | Q53635963 | ||
| In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death. | Q53669552 | ||
| Patients with early onset of type 1 diabetes have significantly higher GG genotype at position 49 of the CTLA4 gene. | Q54706523 | ||
| Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients | Q56902500 | ||
| CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses | Q56904642 | ||
| Stat4-null non-obese diabetic mice: protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread | Q57704182 | ||
| Genetic variants in the tumor necrosis factor receptor II gene in patients with multiple sclerosis | Q59273858 | ||
| Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level | Q60311694 | ||
| IL-4 and IL-12 Regulate Proteoglycan-Induced Arthritis Through Stat-Dependent Mechanisms | Q61658659 | ||
| CC chemokine receptor 5 polymorphism in rheumatoid arthritis | Q63728135 | ||
| Regulation of TCR-mediated T cell activation by TNF-RII | Q73910634 | ||
| Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family | Q73931768 | ||
| Analysis of DNA microarrays by non-destructive fluorescent staining using SYBR green II | Q74040594 | ||
| Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis | Q74385158 | ||
| Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells | Q74410084 | ||
| The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7 | Q74650540 | ||
| Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo | Q77342616 | ||
| Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis | Q77406842 | ||
| The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA) | Q77774922 | ||
| Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively | Q77794826 | ||
| Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1 | Q78127337 | ||
| P433 | issue | 7 | |
| P304 | page(s) | R54 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Genome Biology | Q5533480 |
| P1476 | title | Signatures of human regulatory T cells: an encounter with old friends and new players | |
| P478 | volume | 7 |
| Q38144256 | Advances in siRNA delivery to T-cells: potential clinical applications for inflammatory disease, cancer and infection |
| Q33828647 | Analysis of the transcriptional program of developing induced regulatory T cells |
| Q33490627 | Apoptosis of CD4+ CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation |
| Q37945242 | Cell surface markers in HTLV-1 pathogenesis |
| Q39230061 | Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes |
| Q57463606 | Cycling CD4+ T cells in HIV-infected immune nonresponders have mitochondrial dysfunction |
| Q42181657 | FOXP3 Expression in GARP-Transduced Helper T Cells Is Not Associated with FOXP3 TSDR Demethylation |
| Q33673969 | FOXP3 and GARP (LRRC32): the master and its minion |
| Q39831406 | FOXP3 inhibits activation-induced NFAT2 expression in T cells thereby limiting effector cytokine expression. |
| Q34345373 | First insight into the kinome of human regulatory T cells |
| Q41965323 | GARP: a key receptor controlling FOXP3 in human regulatory T cells |
| Q38542678 | Galectin-3 in autoimmunity and autoimmune diseases |
| Q38511081 | Gene expression signatures of peripheral CD4+ T cells clearly discriminate between patients with acute and chronic hepatitis B infection |
| Q37235679 | Genome-wide DNA methylation analysis identifies hypomethylated genes regulated by FOXP3 in human regulatory T cells |
| Q38510630 | Genotype-dependent tumor regression in Marek's disease mediated at the level of tumor immunity. |
| Q54947687 | Immune cell profiling in cancer: molecular approaches to cell-specific identification. |
| Q33692455 | Implementation of exon arrays: alternative splicing during T-cell proliferation as determined by whole genome analysis |
| Q53060554 | Increased intragraft rejection-associated gene transcripts in patients with donor-specific antibodies and normal biopsies. |
| Q37674407 | Interindividual variation in human T regulatory cells |
| Q33459679 | Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. |
| Q54335403 | Localization of FOXP3-positive cells in renal cell carcinoma. |
| Q39402881 | Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells. |
| Q46230949 | MiRNome and transcriptome aided pathway analysis in human regulatory T cells |
| Q35880117 | MicroRNA profile of circulating CD4-positive regulatory T cells in human adults and impact of differentially expressed microRNAs on expression of two genes essential to their function |
| Q53523527 | Natural Tregs, CD4+CD25+ inhibitory hybridomas, and their cell contact dependent suppression. |
| Q28744304 | Next-generation insights into regulatory T cells: expression profiling and FoxP3 occupancy in Human |
| Q41140315 | PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells |
| Q41900367 | PLAU inferred from a correlation network is critical for suppressor function of regulatory T cells |
| Q34263542 | Perspectives on Regulatory T Cell Therapies |
| Q38245229 | Redefining Strategies to Introduce Tolerance-Inducing Cellular Therapy in Human beings to Combat Autoimmunity and Transplantation Reactions |
| Q38233294 | Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β. |
| Q92095036 | Regulatory T cells use arginase 2 to enhance their metabolic fitness in tissues |
| Q36893499 | Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation |
| Q39730306 | Self-aggregating TIAF1 in lung cancer progression. |
| Q57339913 | Serum Response Factor Contributes Selectively to Lymphocyte Development |
| Q33654352 | Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer |
| Q48119880 | TCR usage, gene expression and function of two distinct FOXP3(+)Treg subsets within CD4(+)CD25(hi) T cells identified by expression of CD39 and CD45RO. |
| Q30498066 | TGF-β induces TIAF1 self-aggregation via type II receptor-independent signaling that leads to generation of amyloid β plaques in Alzheimer's disease. |
| Q35979294 | TIAF1 self-aggregation in peritumor capsule formation, spontaneous activation of SMAD-responsive promoter in p53-deficient environment, and cell death |
| Q92242539 | TNFR2 Signaling Enhances ILC2 Survival, Function, and Induction of Airway Hyperreactivity |
| Q58786844 | TNFR2 ligation in human T regulatory cells enhances IL2-induced cell proliferation through the non-canonical NF-κB pathway |
| Q57704152 | The cellular prion protein is preferentially expressed by CD4+ CD25+ Foxp3+ regulatory T cells |
| Q28590403 | Transcriptome analysis of murine macrophages in response to infection with Streptococcus pyogenes reveals an unusual activation program |
| Q36601077 | Transcriptome profiling of human FoxP3+ regulatory T cells |
| Q35956678 | Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice. |
| Q36605106 | YY1 inhibits differentiation and function of regulatory T cells by blocking Foxp3 expression and activity |
Search more.